Rolf R Engel
Overview
Explore the profile of Rolf R Engel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
3313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feber L, Peter N, Chiocchia V, Schneider-Thoma J, Siafis S, Bighelli I, et al.
JAMA Psychiatry
. 2024 Oct;
82(1):47-56.
PMID: 39412783
Importance: Cognitive deficits are a substantial part of the symptoms of schizophrenia spectrum disorders (SSDs) and contribute heavily to the burden of disease. Antipsychotic drugs are not cognitive enhancers, but...
2.
Heimke F, Furukawa Y, Siafis S, Johnston B, Engel R, Furukawa T, et al.
BMJ Ment Health
. 2024 Feb;
27(1).
PMID: 38388002
Background And Objective: Various ways exist to display the effectiveness of medical treatment options. This study examined various psychiatric, medical and allied professionals' understanding and perceived usefulness of eight effect...
3.
Siafis S, Brandt L, McCutcheon R, Gutwinski S, Schneider-Thoma J, Bighelli I, et al.
Lancet Psychiatry
. 2023 Dec;
11(1):36-46.
PMID: 38043562
Background: There is no consensus on defining relapse in schizophrenia, and scale-derived criteria with unclear clinical relevance are widely used. We aimed to develop an evidence-based scale-derived set of criteria...
4.
Maurus I, Wagner S, Campana M, Roell L, Strauss J, Fernando P, et al.
BJPsych Open
. 2023 Apr;
9(3):e60.
PMID: 37038760
Background: Even before the onset of psychotic symptoms, individuals with schizophrenia display cognitive impairments. Simultaneously, increasing amounts of individuals exhibit dysfunction of the blood-brain barrier (BBB). However, the impact of...
5.
Feber L, Peter N, Schneider-Thoma J, Siafis S, Bighelli I, Hansen W, et al.
Syst Rev
. 2023 Mar;
12(1):54.
PMID: 36959619
Background: There is evidence that antipsychotic drugs differ in their effect on the cognitive symptoms of schizophrenia. So far, there is no comprehensive systematic review available that would enable providers...
6.
Tschentscher N, Woll C, Tafelmaier J, Kriesche D, Bucher J, Engel R, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831842
Cognitive impairment in patients suffering from schizophrenia spectrum disorders has been discussed as a strong predictor for multiple disease outcome variables, such as response to psychotherapy, stable relationships, employment, and...
7.
Kriesche D, Woll C, Tschentscher N, Engel R, Karch S
Eur Arch Psychiatry Clin Neurosci
. 2022 Sep;
273(5):1105-1128.
PMID: 36048295
Previous research suggests a broad range of deficits in major depressive disorder. Our goal was to update the current assumptions and investigate the extent of cognitive impairment in depression in...
8.
Leucht S, Siafis S, Engel R, Schneider-Thoma J, Bighelli I, Cipriani A, et al.
Schizophr Bull
. 2021 Aug;
48(1):27-36.
PMID: 34405881
Background: The magnitude of the superiority of antipsychotics over placebo is debated. One reason is that the effect-size index which is usually used in meta-analyses is in standard deviation units....
9.
Baumgartner J, Grohmann R, Bleich S, Glocker C, Seifert J, Toto S, et al.
World J Biol Psychiatry
. 2021 Jun;
23(2):151-164.
PMID: 34096837
Objectives: The aim of this study was to describe atypical dyskinesias (AtypDs) occurring during treatment with antipsychotic drugs (APDs). AtypDs are dyskinesias showing either an unusual temporal relationship between onset...
10.
Seifert J, Fuhrmann F, Reinhard M, Engel R, Bernegger X, Bleich S, et al.
J Neural Transm (Vienna)
. 2021 May;
128(6):827-843.
PMID: 33977402
Data on drug prescription for outpatients with major depressive disorder (MDD) suggest women are more likely to be treated with psychotropic drugs, while data on sex differences regarding pharmacological treatment...